Jazz Pharmaceuticals PLC (JAZZ)
107.89
-1.85
(-1.69%)
USD |
NASDAQ |
Apr 24, 11:58
Jazz Pharmaceuticals Cash from Investing (Quarterly): 101.80M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.80M |
| September 30, 2023 | -174.30M |
| June 30, 2023 | -85.74M |
| March 31, 2023 | -4.822M |
| December 31, 2022 | -324.38M |
| September 30, 2022 | 4.602M |
| June 30, 2022 | -89.16M |
| March 31, 2022 | -37.29M |
| December 31, 2021 | -10.09M |
| September 30, 2021 | -26.81M |
| June 30, 2021 | -5.912B |
| March 31, 2021 | 737.13M |
| December 31, 2020 | 73.22M |
| September 30, 2020 | -279.64M |
| June 30, 2020 | -741.16M |
| March 31, 2020 | -60.08M |
| December 31, 2019 | -159.05M |
| September 30, 2019 | -159.66M |
| June 30, 2019 | -2.638M |
| March 31, 2019 | 166.05M |
| December 31, 2018 | 39.99M |
| September 30, 2018 | -191.75M |
| June 30, 2018 | -190.58M |
| March 31, 2018 | -52.15M |
| December 31, 2017 | -31.88M |
| Date | Value |
|---|---|
| September 30, 2017 | -203.35M |
| June 30, 2017 | -30.15M |
| March 31, 2017 | -3.574M |
| December 31, 2016 | -1.859M |
| September 30, 2016 | -1.531B |
| June 30, 2016 | -206.27M |
| March 31, 2016 | -12.00M |
| December 31, 2015 | -3.367M |
| September 30, 2015 | -5.159M |
| June 30, 2015 | -12.02M |
| March 31, 2015 | 18.29M |
| December 31, 2014 | -14.17M |
| September 30, 2014 | -83.14M |
| June 30, 2014 | -13.13M |
| March 31, 2014 | -957.20M |
| December 31, 2013 | -3.102M |
| September 30, 2013 | -3.152M |
| June 30, 2013 | -3.567M |
| March 31, 2013 | -6.443M |
| December 31, 2012 | 87.19M |
| September 30, 2012 | -3.749M |
| June 30, 2012 | -561.24M |
| March 31, 2012 | 82.51M |
| December 31, 2011 | -65.60M |
| September 30, 2011 | -13.62M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.912B
Minimum
Jun 2021
737.13M
Maximum
Mar 2021
-376.34M
Average
-60.08M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Alkermes PLC | -20.98M |
| Endo International PLC | -11.65M |
| Medtronic PLC | -707.00M |
| Perrigo Co PLC | -22.80M |
| Iterum Therapeutics PLC | 13.52M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 167.34M |
| Cash from Financing (Quarterly) | -100.31M |
| Free Cash Flow | 1.049B |
| Free Cash Flow Per Share (Quarterly) | 1.999 |
| Free Cash Flow to Equity (Quarterly) | 141.56M |
| Free Cash Flow to Firm (Quarterly) | 247.38M |
| Free Cash Flow Yield | 13.49% |